A hydrogen sulphide-releasing non-steroidal anti-inflammatory, ATB-346, significantly attenuates human myometrial contractions
Open Access
- 4 September 2024
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 77 (1) , 287-294
Abstract
Background: Spontaneous preterm birth is the leading cause of perinatal morbidity and mortality. Tocolytics are drugs used to inhibit uterine contractions in cases of imminent preterm birth, however, few are effective in stopping labour once initiated and all have side effects. Combination approaches involving drugs that target multiple signalling pathways that regulate contractions may increase efficacy, reduce dosage and improve tolerability. Both non-steroidal anti-inflammatory drugs (NSAIDs) and hydrogen sulphide (H2S)-releasing compounds can reduce myometrial contractions. In a novel approach we evaluated the tocolytic properties of ATB-346–a H2S-releasing derivative of the NSAID naproxen, shown clinically to reduce pain and inflammation in arthritis. Methods: Using organ baths, paired strips of human myometrium were exposed to increasing concentrations of ATB-346, or equimolar concentrations (10µM and 30µM) of the parent drug, naproxen, or the H2S-releasing moiety, 4-hydroxy-thiobenzamide (TBZ), alone. The ability of ATB-346 versus the individual components of ATB-346 to decrease ex vivo spontaneous contractions was investigated, and the potency was compared to a known H2S donor, Na2S. Results: Acute application of Na2S produced a concentration-dependent decrease in force amplitude and force integral (area under the curve) of contraction. ATB-346 produced a more profound decrease in contraction compared to equimolar concentrations of naproxen or TZB alone and was more potent than the equivalent concentration of Na2S. Conclusions: ATB-346 exhibits potent tocolytic properties in human myometrium. These exciting results call for further exploration of ATB-346, with a view to repurposing this or similar drugs as novel therapies for delaying preterm labour.Keywords
Funding Information
- Wellbeing of Women
- Federation of European Biochemical Societies
This publication has 42 references indexed in Scilit:
- National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysisThe Lancet, 2023
- Estrogen Regulates Local Cysteine Metabolism in Mouse MyometriumReproductive Sciences, 2020
- Gestational and Hormonal Effects on Magnesium Sulfate’s Ability to Inhibit Mouse Uterine ContractilityReproductive Sciences, 2020
- A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediatorBiochemical Pharmacology, 2018
- Reduced Expression of Hydrogen Sulfide–Generating Enzymes Down-Regulates 15-Hydroxyprostaglandin Dehydrogenase in Chorion during Term and Preterm LaborThe American Journal of Pathology, 2018
- l -Cys/CSE/H 2 S pathway modulates mouse uterus motility and sildenafil effectPharmacological Research, 2016
- Effects of hydrogen sulphide in smooth musclePharmacology & Therapeutics, 2016
- Hydrogen sulfide-releasing anti-inflammatory drugsTrends in Pharmacological Sciences, 2007
- [8] Reassessment of Ellman's reagent1983
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959